188 related articles for article (PubMed ID: 19435838)
1. Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.
Shukla-Dave A; Hricak H; Ishill N; Moskowitz CS; Drobnjak M; Reuter VE; Zakian KL; Scardino PT; Cordon-Cardo C
Clin Cancer Res; 2009 Jun; 15(11):3842-9. PubMed ID: 19435838
[TBL] [Abstract][Full Text] [Related]
2. Correlation of MR imaging and MR spectroscopic imaging findings with Ki-67, phospho-Akt, and androgen receptor expression in prostate cancer.
Shukla-Dave A; Hricak H; Ishill NM; Moskowitz CS; Drobnjak M; Reuter VE; Zakian KL; Scardino PT; Cordon-Cardo C
Radiology; 2009 Mar; 250(3):803-12. PubMed ID: 19244047
[TBL] [Abstract][Full Text] [Related]
3. Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse.
Pucar D; Koutcher JA; Shah A; Dyke JP; Schwartz L; Thaler H; Kurhanewicz J; Scardino PT; Kelly WK; Hricak H; Zakian KL
Clin Prostate Cancer; 2004 Dec; 3(3):174-81. PubMed ID: 15636684
[TBL] [Abstract][Full Text] [Related]
4. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
5. Prostate MRSI predicts outcome in radical prostatectomy patients.
Zakian KL; Hatfield W; Aras O; Cao K; Yakar D; Goldman DA; Moskowitz CS; Shukla-Dave A; Tehrani YM; Fine S; Eastham J; Hricak H
Magn Reson Imaging; 2016 Jun; 34(5):674-81. PubMed ID: 26821278
[TBL] [Abstract][Full Text] [Related]
6. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
[TBL] [Abstract][Full Text] [Related]
7. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
Shukla-Dave A; Hricak H; Akin O; Yu C; Zakian KL; Udo K; Scardino PT; Eastham J; Kattan MW
BJU Int; 2012 May; 109(9):1315-22. PubMed ID: 21933336
[TBL] [Abstract][Full Text] [Related]
8. An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy.
Zakian KL; Hricak H; Ishill N; Reuter VE; Eberhardt S; Moskowitz CS; Shukla-Dave A; Wang L; Scardino PT; Eastham JA; Koutcher JA
J Urol; 2010 Dec; 184(6):2320-7. PubMed ID: 20952035
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI for prostate cancer detection: Preliminary results on quantitative analysis of dynamic contrast enhanced imaging, diffusion-weighted imaging and spectroscopy imaging.
Fusco R; Sansone M; Petrillo M; Setola SV; Granata V; Botti G; Perdonà S; Borzillo V; Muto P; Petrillo A
Magn Reson Imaging; 2016 Sep; 34(7):839-45. PubMed ID: 27071309
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer.
Goltz D; Montani M; Braun M; Perner S; Wernert N; Jung K; Dietel M; Stephan C; Kristiansen G
Pathology; 2015 Dec; 47(7):629-36. PubMed ID: 26517642
[TBL] [Abstract][Full Text] [Related]
11. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy.
Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254
[TBL] [Abstract][Full Text] [Related]
12. The Role of Magnetic Resonance Spectroscopy Imaging Parameters to Predict Early Biochemical Recurrence after Radical Prostatectomy.
Parizi MK; Razi A; Alizadeh S; Kasaeian A
Prague Med Rep; 2019; 120(2-3):74-83. PubMed ID: 31586506
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model.
Tollefson MK; Karnes RJ; Kwon ED; Lohse CM; Rangel LJ; Mynderse LA; Cheville JC; Sebo TJ
Mayo Clin Proc; 2014 Mar; 89(3):308-18. PubMed ID: 24486077
[TBL] [Abstract][Full Text] [Related]
14. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
[TBL] [Abstract][Full Text] [Related]
16. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
17. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Multiparametric Magnetic Resonance Imaging Predicts Biochemical Recurrence in Prostate Cancer after Radical Prostatectomy.
Ho R; Siddiqui MM; George AK; Frye T; Kilchevsky A; Fascelli M; Shakir NA; Chelluri R; Abboud SF; Walton-Diaz A; Sankineni S; Merino MJ; Turkbey B; Choyke PL; Wood BJ; Pinto PA
PLoS One; 2016; 11(6):e0157313. PubMed ID: 27336392
[TBL] [Abstract][Full Text] [Related]
19. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy.
Joseph T; McKenna DA; Westphalen AC; Coakley FV; Zhao S; Lu Y; Hsu IC; Roach M; Kurhanewicz J
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):665-71. PubMed ID: 18760545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
